Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Critical Care
Volume 2017, Article ID 3818407, 5 pages
https://doi.org/10.1155/2017/3818407
Case Report

Use of Hemadsorption in a Case of Pediatric Toxic Shock Syndrome

1Department of Pediatrics, University of Debrecen, Debrecen 4012, Hungary
2Institute of Laboratory Medicine, University of Debrecen, Debrecen 4012, Hungary
3Department of Medicine, Faculty of Medicine, University of Debrecen, Debrecen 4012, Hungary
4Fresenius Medical Care, NephroCare University of Debrecen, Debrecen 4012, Hungary
5HAS-UD Vascular Biology and Myocardial Pathophysiology Research Group, Hungarian Academy of Sciences, Debrecen 4012, Hungary

Correspondence should be addressed to József Balla; moc.akinilkleb@allab

Received 10 May 2017; Accepted 14 June 2017; Published 16 July 2017

Academic Editor: Mehmet Doganay

Copyright © 2017 Andrea Berkes et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. S. DeVries, L. Lesher, P. M. Schlievert et al., “Staphylococcal toxic shock syndrome 2000-2006: Epidemiology, clinical features, and molecular characteristics,” PLoS ONE, vol. 6, no. 8, Article ID e22997, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Lees, A. Rosenberg, A. Hurtado-Doce et al., “Combination of ECMO and cytokine adsorption therapy for severe sepsis with cardiogenic shock and ARDS due to Panton–Valentine leukocidin—positive Staphylococcus aureus pneumonia and H1N1,” Journal of Artificial Organs, vol. 19, no. 4, pp. 399–402, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. G. W. van der Linde and A. F. Grootendorst, “First case of toxic shock treated with haemoadsorption by CytoSorb® in the Netherlands,” Netherlands Journal of Critical Care, vol. 24, pp. 27–29, 2016. View at Google Scholar
  4. M. Gruda, “In vitro adsorption of a broad spectrum of inflammatory mediators with CytoSorb® hemoadsorbent polymer beads,” Critical Care, vol. 20, p. 194, 2016. View at Google Scholar
  5. P. M. Honore, R. Jacobs, O. Joannes-Boyau et al., “Newly designed CRRT membranes for sepsis and SIRS-a pragmatic approach for bedside intensivists summarizing the more recent advances: A systematic structured review,” ASAIO Journal, vol. 59, no. 2, pp. 99–106, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Joannidis, “Continuous renal replacement therapy in sepsis and multisystem organ failure,” Seminars in Dialysis, vol. 22, no. 2, pp. 160–164, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Zhou, Z. Peng, R. Murugan, and J. A. Kellum, “Blood purification and mortality in sepsis: A meta-analysis of randomized trials,” Critical Care Medicine, vol. 41, no. 9, pp. 2209–2220, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Schädler, C. Porzelius, A. Jörres et al., “A multicenter randomized controlled study of an extracorporeal cytokine hemoadsorption device in septic patients,” Critical Care, vol. 17, p. 62, 2013. View at Publisher · View at Google Scholar
  9. K. Kogelmann, D. Jarczak, M. Scheller, and M. Drüner, “Hemoadsorption by CytoSorb in septic patients: a case series,” Critical Care, vol. 21, no. 1, 2017. View at Publisher · View at Google Scholar
  10. C. G. Cirstoveanu, I. Barascu, and S. Mc Kenzie Stancu, “Hemadsorption with Adult CytoSorb® in a Low Weight Pediatric Case,” Case Reports in Critical Care, vol. 2017, Article ID 6987167, pp. 1–5, 2017. View at Publisher · View at Google Scholar
  11. S. David, K. Thamm, B. M. Schmidt, C. S. Falk, and J. T. Kielstein, “Effect of extracorporeal cytokine removal on vascular barrier function in a septic shock patient,” Journal of Intensive Care, vol. 5, no. 12, 2017. View at Publisher · View at Google Scholar